Literature DB >> 23000264

Splenic morphological changes are accompanied by altered baseline immunity in a mouse model of sickle-cell disease.

Steven M Szczepanek1, Jeffrey T McNamara, Eric R Secor, Prabitha Natarajan, Linda A Guernsey, Lauren A Miller, Enrique Ballesteros, Evan Jellison, Roger S Thrall, Biree Andemariam.   

Abstract

Although functional asplenia from infarctions may be a major contributor to increased infectious mortality in sickle-cell disease (SCD), this relationship has not been fully defined. We used the transgenic Berkeley SCD mouse to define blood and splenic immunophenotypic differences in this model compared with C57BL/6 and hemizygous controls. In the serum of SCD mice, we found increased IgG2a and suppressed IgM, IgG2b, and IgA levels. Serum IL-6 levels in SCD mice were elevated, whereas IL-1α, CXCL10, and CCL5 levels were decreased. The blood of SCD mice had higher white blood cell counts, with an increased percentage of lymphocytes and decreases in other leukocytes. Immunophenotyping of lymphocytes revealed higher percentages of CD8(+) and T-regulatory cells and lower percentages of B cells. SCD mouse spleens exhibited histological disorganization, with reduction of defined lymphoid follicles and expansion of red pulp, a greater than fourfold increase in splenic mononuclear cells, marked expansion of the nucleated red blood cell fraction, and B-cell and CD8(+) T-cell lymphopenia. Within the splenic B-cell population, there was a significant decrease in B-1a B cells, with a corresponding decrease in IgA secreting plasma cells in the gut. Confocal microscopy of spleens demonstrated complete disruption of the normal lymphofollicular structure in the white pulp of SCD mice without distinct B, T, and marginal zones. Our findings suggest that altered SCD splenic morphological characteristics result in an impaired systemic immune response.
Copyright © 2012 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23000264      PMCID: PMC3483810          DOI: 10.1016/j.ajpath.2012.07.034

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  31 in total

1.  Enhanced pulmonary and systemic response to endotoxin in transgenic sickle mice.

Authors:  J David Holtzclaw; Daniel Jack; Samuel M Aguayo; James R Eckman; Jesse Roman; Lewis L Hsu
Journal:  Am J Respir Crit Care Med       Date:  2003-12-18       Impact factor: 21.405

2.  Low number of antibody producing cells in patients with sickle cell anemia.

Authors:  N Rautonen; N L Martin; J Rautonen; Y Rooks; W C Mentzer; D W Wara
Journal:  Immunol Lett       Date:  1992-12       Impact factor: 3.685

3.  B-cell changes occur in patients with sickle cell anemia.

Authors:  M Venkataraman; M P Westerman
Journal:  Am J Clin Pathol       Date:  1985-08       Impact factor: 2.493

4.  Reduced levels of CD2+ cells and T-cell subsets in patients with sickle cell anaemia.

Authors:  S A Kaaba; S A al-Harbi
Journal:  Immunol Lett       Date:  1993-07       Impact factor: 3.685

5.  Forced TR2/TR4 expression in sickle cell disease mice confers enhanced fetal hemoglobin synthesis and alleviated disease phenotypes.

Authors:  Andrew D Campbell; Shuaiying Cui; Lihong Shi; Rebekah Urbonya; Andrea Mathias; Kori Bradley; Kwaku O Bonsu; Rhonda R Douglas; Brittne Halford; Lindsay Schmidt; David Harro; Donald Giacherio; Keiji Tanimoto; Osamu Tanabe; James Douglas Engel
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-31       Impact factor: 11.205

6.  Mortality in sickle cell disease. Life expectancy and risk factors for early death.

Authors:  O S Platt; D J Brambilla; W F Rosse; P F Milner; O Castro; M H Steinberg; P P Klug
Journal:  N Engl J Med       Date:  1994-06-09       Impact factor: 91.245

7.  The C-type lectin SIGN-R1 mediates uptake of the capsular polysaccharide of Streptococcus pneumoniae in the marginal zone of mouse spleen.

Authors:  Young-Sun Kang; Jae Y Kim; Sandra A Bruening; Maggi Pack; Anna Charalambous; Alla Pritsker; Thomas M Moran; Jutta M Loeffler; Ralph M Steinman; Chae Gyu Park
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-23       Impact factor: 11.205

8.  Lymphocyte subpopulations in homozygous sickle cell anaemia.

Authors:  M O Adedeji
Journal:  Acta Haematol       Date:  1985       Impact factor: 2.195

9.  B-1a B cells that link the innate and adaptive immune responses are lacking in the absence of the spleen.

Authors:  Hedda Wardemann; Thomas Boehm; Neil Dear; Rita Carsetti
Journal:  J Exp Med       Date:  2002-03-18       Impact factor: 14.307

10.  Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells.

Authors:  D D Taub; A R Lloyd; K Conlon; J M Wang; J R Ortaldo; A Harada; K Matsushima; D J Kelvin; J J Oppenheim
Journal:  J Exp Med       Date:  1993-06-01       Impact factor: 14.307

View more
  12 in total

1.  The sickle cell mouse lung: proinflammatory and primed for allergic inflammation.

Authors:  Biree Andemariam; Alexander J Adami; Anurag Singh; Jeffrey T McNamara; Eric R Secor; Linda A Guernsey; Roger S Thrall
Journal:  Transl Res       Date:  2015-03-16       Impact factor: 7.012

2.  Immunologic characterization suggests reduced alloimmunization in a murine model of thalassemia intermedia.

Authors:  Weili Bao; Hui Zhong; Karina Yazdanbakhsh
Journal:  Transfusion       Date:  2014-05-05       Impact factor: 3.157

Review 3.  Turf wars: exploring splenomegaly in sickle cell disease in malaria-endemic regions.

Authors:  Venée N Tubman; Julie Makani
Journal:  Br J Haematol       Date:  2017-05-11       Impact factor: 6.998

4.  Saccharomyces cerevisiae-derived virus-like particle parvovirus B19 vaccine elicits binding and neutralizing antibodies in a mouse model for sickle cell disease.

Authors:  Rhiannon R Penkert; Neal S Young; Sherri L Surman; Robert E Sealy; Jason Rosch; Philip R Dormitzer; Ethan C Settembre; Sumana Chandramouli; Susan Wong; Jane S Hankins; Julia L Hurwitz
Journal:  Vaccine       Date:  2017-05-26       Impact factor: 3.641

5.  Characterization of a mouse model of sickle cell trait: parallels to human trait and a novel finding of cutaneous sensitization.

Authors:  Katherine J Zappia; Yihe Guo; Dawn Retherford; Nancy J Wandersee; Cheryl L Stucky; Cheryl A Hillery
Journal:  Br J Haematol       Date:  2017-10-12       Impact factor: 6.998

6.  Robust adaptive immune response against Babesia microti infection marked by low parasitemia in a murine model of sickle cell disease.

Authors:  Woelsung Yi; Weili Bao; Marilis Rodriguez; Yunfeng Liu; Manpreet Singh; Vijendra Ramlall; Jeny R Cursino-Santos; Hui Zhong; Catherine M Elton; Gavin J Wright; Avital Mendelson; Xiuli An; Cheryl A Lobo; Karina Yazdanbakhsh
Journal:  Blood Adv       Date:  2018-12-11

7.  Poor Long-Term Efficacy of Prevnar-13 in Sickle Cell Disease Mice Is Associated with an Inability to Sustain Pneumococcal-Specific Antibody Titers.

Authors:  Steven M Szczepanek; Sean Roberts; Kara Rogers; Christina Cotte; Alexander J Adami; Sonali J Bracken; Sharon Salmon; Eric R Secor; Roger S Thrall; Biree Andemariam; Dennis W Metzger
Journal:  PLoS One       Date:  2016-02-24       Impact factor: 3.240

8.  Adrenergic-mediated loss of splenic marginal zone B cells contributes to infection susceptibility after stroke.

Authors:  Laura McCulloch; Craig J Smith; Barry W McColl
Journal:  Nat Commun       Date:  2017-04-19       Impact factor: 14.919

9.  Transgenic sickle cell disease mice have high mortality and dysregulated immune responses after vaccination.

Authors:  Steven M Szczepanek; Eric R Secor; Sonali J Bracken; Linda Guernsey; Ektor Rafti; Adam Matson; Roger S Thrall; Biree Andemariam
Journal:  Pediatr Res       Date:  2013-05-31       Impact factor: 3.756

Review 10.  Histological Disorganization of Spleen Compartments and Severe Visceral Leishmaniasis.

Authors:  Micely d'El-Rei Hermida; Caroline Vilas Boas de Melo; Isadora Dos Santos Lima; Geraldo Gileno de Sá Oliveira; Washington L C Dos-Santos
Journal:  Front Cell Infect Microbiol       Date:  2018-11-13       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.